$1.75
0.010.57%
At close: Sep 19, 7:59 PM EDT
$1.76
0.010.57%
After Hours: 7:59 PM EDT
15 minutes delayed
Esperion Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Esperion Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.05 | $-0.15 | 66.7 % |
Mar 2024 | 2024-05-07 | $0.34 | $0.05 | 580.0 % |
Dec 2023 | 2024-02-27 | $-0.50 | $-0.48 | -4.17 % |
Sep 2023 | 2023-11-07 | $-0.37 | $-0.43 | 14.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $73.83M | $50.59M | 46.0 % |
Mar 2024 | 2024-05-07 | $137.74M | $84.51M | 63.0 % |
Dec 2023 | 2024-02-27 | $32.25M | $28.70M | 12.4 % |
Sep 2023 | 2023-11-07 | $33.97M | $29.58M | 14.8 % |
Esperion Therapeutics (ESPR) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.05, which beat the estimate of $-0.15.
The Actual Revenue was $73.8M, which beat the estimate of $50.6M.
Browse earnings estimates, EPS, and revenue on all stocks.